In agreement, an in vitro analysis that was reported by Yao et al. demonstrated that tumor cells stably expressing CLDN18-ARHGAP26 showed weak cell-cell adhesions and strong invasiveness, through inhibition of the RHOA pathway [5]. The gene discussed is CLDN18; the disease is neoplasm.